Try a new search

Format these results:

Searched for:

in-biosketch:true

person:goldfd01

Total Results:

333


Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup

Decker, Brian S; Goldfarb, David S; Dargan, Paul I; Friesen, Marjorie; Gosselin, Sophie; Hoffman, Robert S; Lavergne, Valéry; Nolin, Thomas D; Ghannoum, Marc
The Extracorporeal Treatments in Poisoning Workgroup was created to provide evidence-based recommendations on the use of extracorporeal treatments in poisoning. Here, the EXTRIP workgroup presents its recommendations for lithium poisoning. After a systematic literature search, clinical and toxicokinetic data were extracted and summarized following a predetermined format. The entire workgroup voted through a two-round modified Delphi method to reach a consensus on voting statements. A RAND/UCLA Appropriateness Method was used to quantify disagreement, and anonymous votes were compiled and discussed in person. A second vote was conducted to determine the final workgroup recommendations. In total, 166 articles met inclusion criteria, which were mostly case reports, yielding a very low quality of evidence for all recommendations. A total of 418 patients were reviewed, 228 of which allowed extraction of patient-level data. The workgroup concluded that lithium is dialyzable (Level of evidence=A) and made the following recommendations: Extracorporeal treatment is recommended in severe lithium poisoning (1D). Extracorporeal treatment is recommended if kidney function is impaired and the [Li(+)] is >4.0 mEq/L, or in the presence of a decreased level of consciousness, seizures, or life-threatening dysrhythmias irrespective of the [Li(+)] (1D). Extracorporeal treatment is suggested if the [Li(+)] is >5.0 mEq/L, significant confusion is present, or the expected time to reduce the [Li(+)] to <1.0 mEq/L is >36 hours (2D). Extracorporeal treatment should be continued until clinical improvement is apparent or [Li(+)] is <1.0 mEq/L (1D). Extracorporeal treatments should be continued for a minimum of 6 hours if the [Li(+)] is not readily measurable (1D). Hemodialysis is the preferred extracorporeal treatment (1D), but continuous RRT is an acceptable alternative (1D). The workgroup supported the use of extracorporeal treatment in severe lithium poisoning. Clinical decisions on when to use extracorporeal treatment should take into account the [Li(+)], kidney function, pattern of lithium toxicity, patient's clinical status, and availability of extracorporeal treatments.
PMCID:4422246
PMID: 25583292
ISSN: 1555-905x
CID: 5125722

Renal principles

Chapter by: Ghannoum, Marc; Goldfarb, David S
in: Goldfrank's toxicologic emergencies by Hoffman, Robert S; Howland, Mary Ann; Lewin, Neal A; Nelson, Lewis; Goldfrank, Lewis R; Flomenbaum, Neal [Eds]
New York : McGraw-Hill Education, [2015]
pp. ?-?
ISBN: 0071801847
CID: 2506022

Principles and techniques applied to enhance elimination

Chapter by: Goldfarb, David S; Ghannoum, Marc
in: Goldfrank's toxicologic emergencies by Hoffman, Robert S; Howland, Mary Ann; Lewin, Neal A; Nelson, Lewis; Goldfrank, Lewis R; Flomenbaum, Neal [Eds]
New York : McGraw-Hill Education, [2015]
pp. ?-?
ISBN: 0071801847
CID: 2506012

PEG-INTERFERON: A RARE CAUSE OF ACUTE INTERSTITIAL NEPHRITIS [Meeting Abstract]

Malieckal, Deepa; Guo, Songchuan; Wieczorek, Rosemarie L; Goldfarb, David S
ISI:000355796500170
ISSN: 1523-6838
CID: 2173082

Hypothesis: Urbanization and exposure to urban heat islands contribute to increasing prevalence of kidney stones

Goldfarb, David S; Hirsch, Jacqueline
The prevalence of kidney stones is increasing worldwide. Various etiologies may in part explain this observation including increased prevalence of diabetes, obesity and the metabolic syndrome, increased dietary protein and salt content, and decreased dietary dairy products. We hypothesize an additional and novel potential contributor to increasing kidney stone prevalence: migration to urban settings, or urbanization, and resultant exposure of the population to the higher temperatures of urban heat islands (UHIs). Both urbanization and exposure to UHIs are worldwide, continuous trends. Because the difference in temperature between rural and urban settings is greater than the increase in temperature caused by global warming, the potential effect of urbanization on stone prevalence may be of greater magnitude. However, demonstration of a convincing link between urbanization and kidney stones is confounded by many variables simultaneously affected by migration to cities, such as changes in occupation, income, and diet. No data have yet been published supporting this proposed association. We explore the plausibility and limitations of this possible etiology of increasing kidney stone prevalence.
PMCID:4648638
PMID: 26372336
ISSN: 1532-2777
CID: 1779222

Urine proteomic analysis in cystinuric children with renal stones

Kovacevic, Larisa; Lu, Hong; Goldfarb, David S; Lakshmanan, Yegappan; Caruso, Joseph A
INTRODUCTION: The gene mutations responsible for cystinuria do not fully explain kidney stone activity, suggesting that specific proteins may serve as promoters of cystine precipitation, aggregation or epithelial adherence. In this study we assessed (1) the differences in the urinary proteins between children with cystinuria and kidney stones (CYS) and healthy controls (HC), with particular attention to the fibrosis-related proteins, and (2) the presence of diagnostic biomarkers for CYS. MATERIAL AND METHODS: We conducted a pilot study comparing individual urinary proteomes of 2 newly diagnosed children with CYS and 2 age- and gender-matched HC, using liquid chromatography-mass spectrometry. Relative protein abundance was estimated using spectral counting. Proteins of interest in both CYS and HC were selected using the following criteria: i) >/=5 spectral counts; ii) >/=2-fold difference in spectral counts; and iii)
PMCID:4540695
PMID: 26076823
ISSN: 1873-4898
CID: 1777152

A RANKLing Case: Denosumab-Induced Hypocalcemia [Meeting Abstract]

Laskowski, Larissa K; Goldfarb, David S; Ferrari, Anna; Kavcsak, Kelly; Howland, Mary Ann; Lugassy, Danny M; Smith, Silas W
ISI:000359883400101
ISSN: 1556-9519
CID: 1764302

Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment

Nobel, Yael R; Cox, Laura M; Kirigin, Francis F; Bokulich, Nicholas A; Yamanishi, Shingo; Teitler, Isabel; Chung, Jennifer; Sohn, Jiho; Barber, Cecily M; Goldfarb, David S; Raju, Kartik; Abubucker, Sahar; Zhou, Yanjiao; Ruiz, Victoria E; Li, Huilin; Mitreva, Makedonka; Alekseyenko, Alexander V; Weinstock, George M; Sodergren, Erica; Blaser, Martin J
Mammalian species have co-evolved with intestinal microbial communities that can shape development and adapt to environmental changes, including antibiotic perturbation or nutrient flux. In humans, especially children, microbiota disruption is common, yet the dynamic microbiome recovery from early-life antibiotics is still uncharacterized. Here we use a mouse model mimicking paediatric antibiotic use and find that therapeutic-dose pulsed antibiotic treatment (PAT) with a beta-lactam or macrolide alters both host and microbiota development. Early-life PAT accelerates total mass and bone growth, and causes progressive changes in gut microbiome diversity, population structure and metagenomic content, with microbiome effects dependent on the number of courses and class of antibiotic. Whereas control microbiota rapidly adapts to a change in diet, PAT slows the ecological progression, with delays lasting several months with previous macrolide exposure. This study identifies key markers of disturbance and recovery, which may help provide therapeutic targets for microbiota restoration following antibiotic treatment.
PMCID:4491183
PMID: 26123276
ISSN: 2041-1723
CID: 1649312

The New Epidemiology of Nephrolithiasis

Shoag, Jonathan; Tasian, Greg E; Goldfarb, David S; Eisner, Brian H
Historically nephrolithiasis was considered a disease of dehydration and abnormal urine composition. However, over the past several decades, much has been learned about the epidemiology of this disease and its relation to patient demographic characteristics and common systemic diseases. Here we review the latest epidemiologic studies in the field.
PMID: 26088071
ISSN: 1548-5609
CID: 1631042

Helicobacter pylori, Oxalobacter formigenes, and risk of kidney stones [Letter]

Goldfarb, David S
PMID: 25792104
ISSN: 1532-2777
CID: 1578492